Literature DB >> 12370490

Heregulin-induced apoptosis.

X-F Le1, C R Varela, R C Bast.   

Abstract

Heregulins (HRGs) are a group of polypeptide factors that are encoded by four different HRG genes that can express multiple isoforms through alternate RNA splicing. A number of HRG isoforms possess both growth stimulatory and growth inhibitory functions that are necessary for their important role in the development and maintenance of the heart, nervous system and epithelial cells in multiple organs including the breast. Growth inhibition by HRG relates to its ability to induce apoptosis, differentiation, and cell cycle G(2) arrest. Current studies suggest that HRGs can induce a unique form of apoptosis. In this article, we review recent progress in characterizing and understanding HRG-induced apoptosis. Particular attention has been given to: (1). the activation of caspases-7 and -9; (2). the role of the anti-apoptotic Bcl-2 protein; and (3). the signaling molecules and pathways that regulate HRG-induced apoptosis, including the p38, JNK, mTOR kinase, and PKC alpha kinase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370490     DOI: 10.1023/a:1020682807922

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  7 in total

1.  Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.

Authors:  Lancelot S McLean; Cheri N Watkins; Petreena Campbell; Dain Zylstra; Leah Rowland; Louisa H Amis; Lia Scott; Crystal E Babb; W Joel Livingston; Agus Darwanto; Willie L Davis; Maheswari Senthil; Lawrence C Sowers; Eileen Brantley
Journal:  Chem Res Toxicol       Date:  2015-04-01       Impact factor: 3.739

2.  Synergistic interactions between heregulin and peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist in breast cancer cells.

Authors:  Bae-Hang Park; Sean-Bong Lee; Donna B Stolz; Yong J Lee; Byeong-Chel Lee
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

Review 3.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

4.  Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.

Authors:  A A Memon; B S Sorensen; P Melgard; L Fokdal; T Thykjaer; E Nexo
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

5.  The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination.

Authors:  Graham Skelhorne-Gross; Christopher J B Nicol
Journal:  PPAR Res       Date:  2012-07-02       Impact factor: 4.964

6.  HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK.

Authors:  Daphne Gschwantler-Kaulich; Thomas W Grunt; Daniela Muhr; Renate Wagner; Heinz Kölbl; Christian F Singer
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

Review 7.  Role of tyrosine kinases in bladder cancer progression: an overview.

Authors:  Amir Sadra Zangouei; Amir Hossein Barjasteh; Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Cell Commun Signal       Date:  2020-08-14       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.